239 results on '"Caljon, Guy"'
Search Results
2. Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
3. A breath of fresh air: impact of insect-borne protozoan parasites on the respiratory system
4. The ongoing risk of Leishmania donovani transmission in eastern Nepal: an entomological investigation during the elimination era
5. Synthesis and pharmacological evaluation of fluoro/chloro-substituted acetyl and benzoyl esters of quinine as antimalarial agents
6. Open Synthesis Network Research in an Undergraduate Laboratory: Development of Benzoxazole Amide Derivatives against 'Leishmania' Parasite
7. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
8. Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents
9. Nucleoside analogues for the treatment of animal trypanosomiasis
10. 3-nitroimidazo[1,2-b]pyridazine as a novel scaffold for antiparasitics with sub-nanomolar anti-Giardia lamblia activity
11. Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents
12. Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis
13. Impact of pulmonary African trypanosomes on the immunology and function of the lung
14. N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation
15. Antiplasmodial activity of constituents and their metabolites after in vitro gastrointestinal biotransformation of a Nauclea pobeguinii extract
16. Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents.
17. Effect of Leishmania infantum infection on B cell lymphopoiesis and memory in the bone marrow and spleen.
18. N‐Pyrazolyl‐ and N‐Triazolylamines and ‐Ureas as Antileishmanial and Antitrypanosomal Drugs.
19. 6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents
20. Synthesis and evaluation of 3′-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents
21. Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents
22. Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment.
23. Metronidazole Interaction with Cu2+ and Zn2+: Speciation Study in Aqueous Solution and Biological Activity Evaluation.
24. In Vivo Bioluminescence Imaging Reveals Differences in Leishmania infantum Parasite Killing Kinetics by Antileishmanial Reference Drugs.
25. Dengue Virus Serotype 1 Effects on Mosquito Survival Differ among Geographically Distinct Aedes aegypti Populations.
26. Novel quinoline derivatives with broad‐spectrum antiprotozoal activities.
27. Synthesis and Anti-Trypanosoma cruzi Activity of 3‑Cyanopyridine Derivatives.
28. Practical and Divergent Synthesis of Carbocyclic Pyrazolo[3,4‐d]pyrimidine Nucleoside Analogues.
29. Design and Synthesis of 1,3-Diarylpyrazoles and Investigation of Their Cytotoxicity and Antiparasitic Profile.
30. Sand Fly Studies Predict Transmission Potential of Drug-resistant Leishmania
31. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents
32. Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
33. C6–O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents
34. Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
35. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity
36. Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity
37. Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites.
38. Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents.
39. Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection.
40. Lead Optimization of the 5‑Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy.
41. Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives
42. Novel triazine dimers with potent antitrypanosomal activity
43. Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility
44. Comparative analysis of the internalization of the macrophage receptor sialoadhesin in human and mouse primary macrophages and cell lines
45. A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation
46. Evaluation of a pan-Leishmania SL RNA qPCR assay for parasite detection in laboratory-reared and field-collected sand flies and reservoir hosts
47. Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection
48. Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness
49. Dual N6/C7-Substituted 7‑Deazapurine and Tricyclic Ribonucleosides with Affinity for G Protein-Coupled Receptors.
50. Design and synthesis of imidazo[1,2‐a]pyridine‐chalcone conjugates as antikinetoplastid agents.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.